The abstracts include the following:
- C-1033, from Dr. Gisella Gennaro of the Veneto Institute of Oncology in Padua, Italy
- C-1770 and C-1762, from Ralph Highnam, PhD, CEO of Matakina International
- C-1953, from Dr. Nico Karssemeijer of Radboud University Medical Centre in Nijmegen, the Netherlands
- C-1787, from Dr. Kwan Ng of the University of Malaya in Kuala Lumpur, Malaysia
In other Matakina news, Volpara has been chosen for use in the European Union collaborative Adapting Breast Cancer Screening Strategy Using Personalized Risk Estimation (ASSURE) research project, the company said.
Copyright © 2013 AuntMinnieEurope.com